Evandro Piva1, Susan A Tarlé2, Jacques E Nör3, Duohong Zou2, Elizabeth Hatfield2, Tyler Guinn2, Emily J Eubanks2, Darnell Kaigler4. 1. Department of Cariology and Restorative Sciences, School of Dentistry, University of Michigan, Ann Arbor, Michigan. 2. Department of Periodontics and Oral Medicine, School of Dentistry, University of Michigan, Ann Arbor, Michigan. 3. Department of Cariology and Restorative Sciences, School of Dentistry, University of Michigan, Ann Arbor, Michigan; Department of Biomedical Engineering, College of Engineering, University of Michigan, Ann Arbor, Michigan. 4. Department of Periodontics and Oral Medicine, School of Dentistry, University of Michigan, Ann Arbor, Michigan; Department of Biomedical Engineering, College of Engineering, University of Michigan, Ann Arbor, Michigan. Electronic address: dkaigler@umich.edu.
Abstract
INTRODUCTION: Dental pulp-derived stem cells (DPSCs) have the potential to regenerate dentin and dental pulp tissue because of their differentiation capacity and angiogenic properties. However, for regenerative approaches to gain regulatory and clinical acceptance, protocols are needed to determine more feasible ways to cultivate DPSCs, namely, without the use of xenogeneic-derived components (animal sera) and exogenous growth factors. METHODS: In this study, human DPSCs were isolated from third molars and expanded in standard culture conditions containing fetal bovine serum (DPSCs-FBS) or conditions containing human serum (DPSCs-HS). After cell characterization and evaluation of their angiogenic secretome, DPSCs were seeded in tooth slice/scaffolds and implanted subcutaneously into immunodeficient mice. After 30 days, tooth slices were retrieved and evaluated for dental pulp tissue regeneration. Immunohistochemistry and confocal microscopy were used to quantify blood vessel formation and evaluate predentin and dentin formation. RESULTS: After culture, DPSCs-HS produced concentrations of angiogenic growth factors equivalent to DPSCs-FBS. Additionally, in DPSCs-HS, several angiogenic factors were produced in at least 1-fold higher concentrations than in DPSCs-FBS. In vivo, it was determined that DPSCs-HS produced a robust angiogenic response and regeneration of dentin equivalent to DPSCs-FBS. CONCLUSIONS: These findings show that DPSCs can be isolated and expanded to clinical scale numbers in media devoid of animal serum or exogenous growth factors and still maintain their pulp regenerative properties. The implications of these findings are significant for further development of clinical protocols using DPSCs in cell therapies.
INTRODUCTION: Dental pulp-derived stem cells (DPSCs) have the potential to regenerate dentin and dental pulp tissue because of their differentiation capacity and angiogenic properties. However, for regenerative approaches to gain regulatory and clinical acceptance, protocols are needed to determine more feasible ways to cultivate DPSCs, namely, without the use of xenogeneic-derived components (animal sera) and exogenous growth factors. METHODS: In this study, human DPSCs were isolated from third molars and expanded in standard culture conditions containing fetal bovine serum (DPSCs-FBS) or conditions containing human serum (DPSCs-HS). After cell characterization and evaluation of their angiogenic secretome, DPSCs were seeded in tooth slice/scaffolds and implanted subcutaneously into immunodeficientmice. After 30 days, tooth slices were retrieved and evaluated for dental pulp tissue regeneration. Immunohistochemistry and confocal microscopy were used to quantify blood vessel formation and evaluate predentin and dentin formation. RESULTS: After culture, DPSCs-HS produced concentrations of angiogenic growth factors equivalent to DPSCs-FBS. Additionally, in DPSCs-HS, several angiogenic factors were produced in at least 1-fold higher concentrations than in DPSCs-FBS. In vivo, it was determined that DPSCs-HS produced a robust angiogenic response and regeneration of dentin equivalent to DPSCs-FBS. CONCLUSIONS: These findings show that DPSCs can be isolated and expanded to clinical scale numbers in media devoid of animal serum or exogenous growth factors and still maintain their pulp regenerative properties. The implications of these findings are significant for further development of clinical protocols using DPSCs in cell therapies.
Authors: Flavio F Demarco; Luciano Casagrande; Zhaocheng Zhang; Zhihong Dong; Sandra B Tarquinio; Benjamin D Zeitlin; Songtao Shi; Anthony J Smith; Jacques E Nör Journal: J Endod Date: 2010-09-19 Impact factor: 4.171
Authors: Brandon C Perry; Dan Zhou; Xiaohua Wu; Feng-Chun Yang; Michael A Byers; T-M Gabriel Chu; J Jeffrey Hockema; Erik J Woods; W Scott Goebel Journal: Tissue Eng Part C Methods Date: 2008-06 Impact factor: 3.056
Authors: Annelies Bronckaers; Petra Hilkens; Yanick Fanton; Tom Struys; Pascal Gervois; Constantinus Politis; Wendy Martens; Ivo Lambrichts Journal: PLoS One Date: 2013-08-07 Impact factor: 3.240
Authors: Zhou Xuedong; Huang Dingming; Liu Jianguo; Huang Zhengwei; Wei Xin; Yang Deqin; Zhao Jin; Chen Liming; Zhu Lin; Li Yanhong; Li Jiyao Journal: Hua Xi Kou Qiang Yi Xue Za Zhi Date: 2017-08-01
Authors: Sarah Hani Shoushrah; Janis Lisa Transfeld; Christian Horst Tonk; Dominik Büchner; Steffen Witzleben; Martin A Sieber; Margit Schulze; Edda Tobiasch Journal: Int J Mol Sci Date: 2021-06-15 Impact factor: 5.923
Authors: Beatriz A Rodas-Junco; Michel Canul-Chan; Rafael A Rojas-Herrera; Clelia De-la-Peña; Geovanny I Nic-Can Journal: Front Physiol Date: 2017-12-06 Impact factor: 4.566
Authors: Alejandro Victoria-Escandell; José Santiago Ibañez-Cabellos; Sergio Bañuls-Sánchez de Cutanda; Ester Berenguer-Pascual; Jesús Beltrán-García; Eva García-López; Federico V Pallardó; José Luis García-Giménez; Antonio Pallarés-Sabater; Ignacio Zarzosa-López; Manuel Monterde Journal: Stem Cells Int Date: 2017-05-24 Impact factor: 5.443
Authors: Katarzyna Stefańska; Katarzyna Ożegowska; Greg Hutchings; Małgorzata Popis; Lisa Moncrieff; Claudia Dompe; Krzysztof Janowicz; Wojciech Pieńkowski; Paweł Gutaj; Jamil A Shibli; Walterson Mathias Prado; Hanna Piotrowska-Kempisty; Paul Mozdziak; Małgorzata Bruska; Maciej Zabel; Bartosz Kempisty; Michał Nowicki Journal: J Clin Med Date: 2020-04-12 Impact factor: 4.241